Ki-67 expression as a prognostic factor in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP.

Yoon, Dok Hyun

Ki-67 expression as a prognostic factor in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP. [electronic resource] - European journal of haematology Aug 2010 - 149-57 p. digital

Publication Type: Journal Article

1600-0609

10.1111/j.1600-0609.2010.01467.x doi


Adolescent
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Cell Proliferation--drug effects
Cyclophosphamide--administration & dosage
Doxorubicin--administration & dosage
Humans
Ki-67 Antigen--analysis
Lymphoma, Large B-Cell, Diffuse--diagnosis
Middle Aged
Prednisone--administration & dosage
Prognosis
Recurrence
Rituximab
Survival Analysis
Vincristine--administration & dosage
Young Adult